European Arm12 Feb 2025 11:24
Since Creo sold 51% of its European subsidiary for €72 million, that means the total 100% valuation of the subsidiary can be calculated as:
72
𝑀
0.51
≈
141.18
𝑀
0.51
72M
≈141.18M
So, the deal values Creo Medical S.L.U. (the European subsidiary) at approximately €141 million, which is around £118 million based on the exchange rate we used earlier.
POINT: this is European arm only - so this means the overall business true value would be a significantly more? the current market cap is only £88m.. so significantly undervalued.